Allergies & Asthma

It’s probably no surprise that the most significant respiratory disease epidemic in 100 years is the number one subject at this year’s CHEST meeting. But healthcare professionals with interests in more traditional topics shouldn’t feel cheated, a review of abstracts and scheduled sessions indicates. Of the nearly 2,100 abstracts published ahead of the meeting —
0 Comments
Around 16.5 million adults in the U.S. have eczema.1 And of those, 6.6 million have moderate-to-severe eczema. Atopic dermatitis is the most common type of eczema. But despite such a large number of people with eczema, it’s still widely misunderstood. October is National Eczema Awareness Month. We can work together to spread eczema awareness and
0 Comments
Are you one of the over 50 million Americans who experiences allergies each year? Signs and symptoms of an allergic reaction can range from a bothersome stuffy/runny nose, sneezing, and itchy/watery eyes to a rash, difficulty swallowing and anaphylaxis. What actually happens during an allergic reaction? Is there a way to treat the cause? We’ll
0 Comments
In today’s world, there are endless options for the same or similar services – even when it comes to healthcare. We understand that it can be difficult to decide which allergy skin test option is best for you, or to know who or what to trust when it comes to diagnosing your allergies. Dr. Mary
0 Comments
The Asthma and Allergy Foundation of America report on Asthma Disparities in America looks at the burden of asthma on racial/ethnic groups in the United States. Health disparities are preventable health differences between groups of people. They are higher burdens of illness or death linked to social, economic, and environmental disadvantages. For example, if one
0 Comments
Is having dyslexia a gift or a superpower? Princess Beatrice recently spoke about her experience of having dyslexia. She referenced it as having a gift. This of course has sparked some debate among others with dyslexia. An article written in The Scotsman newspaper recently gave a very real account of what it is like to
0 Comments
Who knew attending events virtually was just as tiring as in person events. When you live with a chronic illness pacing is not a new concept. We have to continually make decisions about what we events we are going to attend, what we will miss and also what events are worth several days recovery and
0 Comments
[embedded content] I was asked to record a video for part of the Respiratory Critical Care session at the European Respiratory Society Congress. The session was titled “New Developments in Mechanical Ventilation and Ventilator Weaning” and my video was to focus on my experience of being weaned from a ventilator. Im not going to lie
0 Comments
If you care for someone with asthma, have you noticed that their asthma always seem to get worse in September? If so, you’re not alone. In fact, researchers have studied this issue. Here is what they found. September Is a Difficult Time for People With Asthma There is a September asthma hospital stay “epidemic.” In
0 Comments
Researchers looking for post-breastfeeding dietary patterns in two prospective birth cohorts that predispose infants to asthma found one, and it wasn’t what anyone expected. After switching from breast milk, babies up to age 1 whose protein intake came largely from meat products — as opposed to dairy, fish, or egg proteins — showed more than
0 Comments
Several studies caught our eye at the just-concluded European Respiratory Society’s virtual annual meeting. Among them: more negative findings for ivermectin as a COVID-19 treatment; clinical performance of a novel image-analysis system that determines in real time whether lung tissue biopsies collected during surgery contain malignant cells; and insights into just how triple therapy for
0 Comments
Two studies presented at the European Respiratory Society (ERS) virtual meeting should reassure asthma patients and their physicians about their risks from COVID-19. On the one hand, “no evidence of excess deaths was directly attributed to asthma” in a study of Scottish data on hospital admissions and death certificates during the first COVID-19 wave in
0 Comments
One study of an immunotherapy for reducing chronic obstructive pulmonary disease (COPD) exacerbations missed its primary endpoint and failed to show a statistically significant benefit even in the subgroup that showed the greatest response. Another study, involving a similar product, showed results so dramatic that an independent expert suspected they were “too good to be
0 Comments
Exercise capacity in patients with chronic obstructive pulmonary disease (COPD) increased substantially following a single IV iron infusion, a researcher reported. With patients’ tolerance for physical activity measured with two standard assessments — the 6-minute walk test (6MWT) and a constant work-rate exercise test — more than half the patients receiving the infusion achieved the
0 Comments
Here’s another likely health impact from climate change to add to the ever-growing list: more frequent chronic obstructive pulmonary disease (COPD) exacerbations. Each 1°C increment in outdoor temperature, after adjustment for humidity levels, was associated with a 2% increase in odds that COPD patients would experience exacerbations 2 days later (P=0.002), reported Supaksh Gupta, MD,
0 Comments
Managing your allergies can be costly — especially when your daily antihistamine isn’t cutting out all of your symptoms. With so many products that claim to reduce allergy symptoms, it can be difficult to know which are worth the investment. In this blog, read about three of the top allergy products that we find to
0 Comments
Most highly allergic adults were able to safely receive the two-dose series of the Pfizer/BioNTech COVID-19 vaccine (BNT162b2; Comirnaty), a prospective single-center study found. Of 429 highly allergic patients who received the first dose of the mRNA vaccine, mild allergic reactions occurred in 1.4% and 0.7% experienced anaphylaxis, reported Nancy Agmon-Levin, MD, of Sheba Medical
0 Comments
To bring the voice of patients and caregivers impacted by asthma in childhood to the forefront of drug development and research, the Allergy & Asthma Network, American Lung Association, American Partnership for Eosinophilic Disorders, and Asthma and Allergy Foundation of America (AAFA) are collaborating on a new program – Little Airways, Big Voices. You can
0 Comments